Glucocorticoids induce effector T cell depolarization via ERM proteins, thereby impeding migration and APC conjugation

Journal of Immunology

Volumn 190, Issue 8, 2013, Pages 4360-4370

  Müller, Nora ^a   Fischer, Henrike J ^b   Tischner, Denise ^b,c   Van Den Brandt, Jens ^b,d   Reichardt, Holger M ^a,b  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^c MAX PLANCK INSTITUTE FOR HEART AND LUNG RESEARCH   (Germany)

^d UNIVERSITY OF GREIFSWALD   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EZRIN; F ACTIN; GLUCOCORTICOID; MOESIN; PHOSPHOLIPASE C; RADIXIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN ANTIBODY COMPLEX; ANTIGEN PRESENTING CELL; APOPTOSIS; ARTICLE; CELL ADHESION; CELL INTERACTION; CELL ISOLATION; CELL MIGRATION; CELL STRUCTURE; CONFOCAL LASER MICROSCOPY; CONJUGATION; CONTROLLED STUDY; CYTOSKELETON; DEPOLARIZATION; EFFECTOR CELL; ENZYME ACTIVITY; GENE EXPRESSION; GENETIC TRANSCRIPTION; IMMUNOFLUORESCENCE TEST; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; LYMPHOCYTE FUNCTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; RAT;

ANIMALS; ANTIGEN-PRESENTING CELLS; CELL MIGRATION INHIBITION; CELL POLARITY; CELLS, CULTURED; CYTOSKELETAL PROTEINS; DEXAMETHASONE; MEMBRANE PROTEINS; MICROFILAMENT PROTEINS; RATS; RATS, INBRED LEW; RATS, TRANSGENIC; T-LYMPHOCYTE SUBSETS;

EID: 84875973320     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1201520     Document Type: Article

References (37)

1. Billadeau, D. D., J. C. Nolz, and T. S. Gomez. 2007. Regulation of T-cell activation by the cytoskeleton. Nat. Rev. Immunol. 7: 131-143.
2. Krummel, M. F., and I. Macara. 2006. Maintenance and modulation of T cell polarity. Nat. Immunol. 7: 1143-1149.
3. Faure, S., L. I. Salazar-Fontana, M. Semichon, V. L. Tybulewicz, G. Bismuth, A. Trautmann, R. N. Germain, and J. Delon. 2004. ERM proteins regulate cytoskeleton relaxation promoting T cell-APC conjugation. Nat. Immunol. 5: 272-279.
4. Shaffer, M. H., R. S. Dupree, P. Zhu, I. Saotome, R. F. Schmidt, A. I. McClatchey, B. D. Freedman, and J. K. Burkhardt. 2009. Ezrin and moesin function together to promote T cell activation. J. Immunol. 182: 1021-1032.
5. Brown, M. J., R. Nijhara, J. A. Hallam, M. Gignac, K. M. Yamada, S. L. Erlandsen, J. Delon, M. Kruhlak, and S. Shaw. 2003. Chemokine stimulation of human peripheral blood T lymphocytes induces rapid dephosphorylation of ERM proteins, which facilitates loss of microvilli and polarization. Blood 102: 3890-3899.
6. Tuckermann, J. P., A. Kleiman, K. G. McPherson, and H. M. Reichardt. 2005. Molecular mechanisms of glucocorticoids in the control of inflammation and lymphocyte apoptosis. Crit. Rev. Clin. Lab. Sci. 42: 71-104.
7. Beato, M., P. Herrlich, and G. Schütz. 1995. Steroid hormone receptors: many actors in search of a plot. Cell 83: 851-857.
8. Limbourg, F. P., Z. Huang, J. C. Plumier, T. Simoncini, M. Fujioka, J. Tuckermann, G. Schütz, M. A. Moskowitz, and J. K. Liao. 2002. Rapid nontranscriptional activation of endothelial nitric oxide synthase mediates increased cerebral blood flow and stroke protection by corticosteroids. J. Clin. Invest. 110: 1729-1738.
9. Song, I. H., and F. Buttgereit. 2006. Non-genomic glucocorticoid effects to provide the basis for new drug developments. Mol. Cell. Endocrinol. 246: 142-146.
10. Reichardt, H. M., and F. Lühder. 2012. The ambivalent role of apoptosis in experimental autoimmune encephalomyelitis and multiple sclerosis. Curr. Pharm. Des. 18: 4453-4464.
11. Herold, M. J., K. G. McPherson, and H. M. Reichardt. 2006. Glucocorticoids in T cell apoptosis and function. Cell. Mol. Life Sci. 63: 60-72.
12. Almawi, W. Y., H. N. Beyhum, A. A. Rahme, and M. J. Rieder. 1996. Regulation of cytokine and cytokine receptor expression by glucocorticoids. J. Leukoc. Biol. 60: 563-572.
13. Chen, X., J. J. Oppenheim, R. T. Winkler-Pickett, J. R. Ortaldo, and O. M. Howard. 2006. Glucocorticoid amplifies IL-2-dependent expansion of functional FoxP3(+)CD4(+)CD25(+) T regulatory cells in vivo and enhances their capacity to suppress EAE. Eur. J. Immunol. 36: 2139-2149.
14. Wüst, S., J. van den Brandt, D. Tischner, A. Kleiman, J. P. Tuckermann, R. Gold, F. Lühder, and H. M. Reichardt. 2008. Peripheral T cells are the therapeutic targets of glucocorticoids in experimental autoimmune encephalomyelitis. J. Immunol. 180: 8434-8443.
15. Cifone, M. G., G. Migliorati, R. Parroni, C. Marchetti, D. Millimaggi, A. Santoni, and C. Riccardi. 1999. Dexamethasone-induced thymocyte apoptosis: apoptotic signal involves the sequential activation of phosphoinositide-specific phospholipase C, acidic sphingomyelinase, and caspases. Blood 93: 2282-2296.
16. Löwenberg, M., J. Tuynman, J. Bilderbeek, T. Gaber, F. Buttgereit, S. van Deventer, M. Peppelenbosch, and D. Hommes. 2005. Rapid immunosuppressive effects of glucocorticoids mediated through Lck and Fyn. Blood 106: 1703-1710.
17. Gold, R., G. Giegerich, H. P. Hartung, and K. V. Toyka. 1995. T-cell receptor (TCR) usage in Lewis rat experimental autoimmune encephalomyelitis: TCR beta-chain-variable-region V beta 8.2-positive T cells are not essential for induction and course of disease. Proc. Natl. Acad. Sci. USA 92: 5850-5854.
18. Tischner, D., A. Weishaupt, J. van den Brandt, N. Müller, N. Beyersdorf, C. W. Ip, K. V. Toyka, T. Hünig, R. Gold, T. Kerkau, and H. M. Reichardt. 2006. Polyclonal expansion of regulatory T cells interferes with effector cell migration in a model of multiple sclerosis. Brain 129: 2635-2647.
19. Tischner, D., J. van den Brandt, A. Weishaupt, F. Lühder, M. J. Herold, and H. M. Reichardt. 2009. Stable silencing of the glucocorticoid receptor in myelin-specific T effector cells by retroviral delivery of shRNA: insight into neuro-inflammatory disease. Eur. J. Immunol. 39: 2361-2370.
20. Müller, N., J. van den Brandt, F. Odoardi, D. Tischner, J. Herath, A. Flügel, and H. M. Reichardt. 2008. A CD28 superagonistic antibody elicits 2 functionally distinct waves of T cell activation in rats. J. Clin. Invest. 118: 1405-1416.
21. Robertson, A. M., C. C. Bird, A. W. Waddell, and A. R. Currie. 1978. Morphological aspects of glucocorticoid-induced cell death in human lymphoblastoid cells. J. Pathol. 126: 181-187.
22. Reichardt, H. M., K. H. Kaestner, J. Tuckermann, O. Kretz, O. Wessely, R. Bock, P. Gass, W. Schmid, P. Herrlich, P. Angel, and G. Schütz. 1998. DNA binding of the glucocorticoid receptor is not essential for survival. Cell 93: 531-541.
23. Wang, D., N. Müller, K. G. McPherson, and H. M. Reichardt. 2006. Glucocorticoids engage different signal transduction pathways to induce apoptosis in thymocytes and mature T cells. J. Immunol. 176: 1695-1702.
24. Marelli-Berg, F. M., L. Cannella, F. Dazzi, and V. Mirenda. 2008. The highway code of T cell trafficking. J. Pathol. 214: 179-189.
25. Smith, A., P. Stanley, K. Jones, L. Svensson, A. McDowall, and N. Hogg. 2007. The role of the integrin LFA-1 in T-lymphocyte migration. Immunol. Rev. 218: 135-146.
26. Friedl, P., A. T. den Boer, and M. Gunzer. 2005. Tuning immune responses: diversity and adaptation of the immunological synapse. Nat. Rev. Immunol. 5: 532-545.
27. Ren, L., S. H. Hong, J. Cassavaugh, T. Osborne, A. J. Chou, S. Y. Kim, R. Gorlick, S. M. Hewitt, and C. Khanna. 2009. The actin-cytoskeleton linker protein ezrin is regulated during osteosarcoma metastasis by PKC. Oncogene 28: 792-802.
28. Belkina, N. V., Y. Liu, J. J. Hao, H. Karasuyama, and S. Shaw. 2009. LOK is a major ERM kinase in resting lymphocytes and regulates cytoskeletal rearrangement through ERM phosphorylation. Proc. Natl. Acad. Sci. USA 106: 4707-4712.
29. Pietromonaco, S. F., P. C. Simons, A. Altman, and L. Elias. 1998. Protein kinase C-theta phosphorylation of moesin in the actin-binding sequence. J. Biol. Chem. 273: 7594-7603.
30. Pearson, K. 1909. Determination of the Coefficient of Correlation. Science 30: 23-25.
31. Harrington, W. R., S. H. Kim, C. C. Funk, Z. Madak-Erdogan, R. Schiff, J. A. Katzenellenbogen, and B. S. Katzenellenbogen. 2006. Estrogen dendrimer conjugates that preferentially activate extranuclear, nongenomic versus genomic pathways of estrogen action. Mol. Endocrinol. 20: 491-502.
32. Bartholome, B., C. M. Spies, T. Gaber, S. Schuchmann, T. Berki, D. Kunkel, M. Bienert, A. Radbruch, G. R. Burmester, R. Lauster, et al. 2004. Membrane glucocorticoid receptors (mGCR) are expressed in normal human peripheral blood mononuclear cells and up-regulated after in vitro stimulation and in patients with rheumatoid arthritis. FASEB J. 18: 70-80.
33. Revankar, C. M., D. F. Cimino, L. A. Sklar, J. B. Arterburn, and E. R. Prossnitz. 2005. A transmembrane intracellular estrogen receptor mediates rapid cell signaling. Science 307: 1625-1630.
34. Löwenberg, M., A. P. Verhaar, G. R. van den Brink, and D. W. Hommes. 2007. Glucocorticoid signaling: a nongenomic mechanism for T-cell immunosup-pression. Trends Mol. Med. 13: 158-163.
35. Samstag, Y., S. M. Eibert, M. Klemke, and G. H. Wabnitz. 2003. Actin cytoskeletal dynamics in T lymphocyte activation and migration. J. Leukoc. Biol. 73: 30-48.
36. Ng, T., M. Parsons, W. E. Hughes, J. Monypenny, D. Zicha, A. Gautreau, M. Arpin, S. Gschmeissner, P. J. Verveer, P. I. Bastiaens, and P. J. Parker. 2001. Ezrin is a downstream effector of trafficking PKC-integrin complexes involved in the control of cell motility. EMBO J. 20: 2723-2741.
37. Liu, Y., N. V. Belkina, C. Park, R. Nambiar, S. M. Loughhead, G. Patino-Lopez, K. Ben-Aissa, J. J. Hao, M. J. Kruhlak, H. Qi, et al. 2012. Constitutively active ezrin increases membrane tension, slows migration, and impedes endothelial transmigration of lymphocytes in vivo in mice. Blood 119: 445-453.